Brainstorm Cell Therapeutics (BCLI) Misses Q3 EPS by 19c

November 14, 2025 5:48 PM

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q3 EPS of ($0.19).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.